Analysis of factors that might affect the patients' PFS suggested that poor CP classification could be an independent risk factor in u-HCC; therefore, patients with poor hepatic functional reserve might be less likely to benefit from the triple therapy than those with good hepatic reserve. The gene discussed is CP; the disease is hepatocellular carcinoma.